Upgrade to SI Premium - Free Trial

Jefferies Downgrades Teva Pharma (TEVA) to Hold; Too Many Headwinds

November 16, 2016 6:32 AM
Jefferies downgraded Teva Pharma (NYSE: TEVA) from Buy to Hold with a price target of $40.00 (from $69.00), saying there ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst EPS Change Analyst EPS View Analyst PT Change Downgrades

Next Articles